Paul Cornwell, PhD, DABT

Executive Director
Eli Lilly and Co, Inc.

Presentation(s):

• Managing Nonmutagenic Impurities in Pharmaceuticals: Emerging Science (S13)

  Tuesday, November 19, 2024
  2:00 PM - 5:00 PM CT

• Analysis of Non-Mutagenic Substances in the Context of Drug Impurity Assessment—Few are Potent Toxicants (S13-6)

  Tuesday, November 19, 2024
  4:00 PM - 4:15 PM CT